ANAPTYSBIO, INC 10-K filing
Filed 2026-03-03 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001193125-26-088290
- Form type
- 10-K
- CIK
- 0001370053
- Primary document
- https://www.sec.gov/Archives/edgar/data/1370053/000119312526088290/anab-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANAPTYSBIO, INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $234.6M | - | - |
| Operating Income | $47.9M | - | - |
| Net Income | $-13.2M | - | - |
| Eps Basic | -0.46 | - | - |
| Eps Diluted | -0.46 | - | - |
| Cash And Equivalents | $238.2M | - | - |
| Total Assets | $364.4M | - | - |
| Shareholders Equity | $37.2M | - | - |
| Operating Cash Flow | $19.7M | - | - |
| Capital Expenditures | $87,000 | - | - |